Shares of Elevance Health Inc. ELV slipped 1.42% to $405.40 Tuesday, on what proved to be an all-around great trading session ...

Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.

We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click here to read more.

Elevance Health topped profit and revenue expectations for the fourth quarter and is guiding for more gains from premiums and products in the year ahead. The health insurer formerly known as ...

Elevance Health's board has raised the health insurer and healthcare-services provider's quarterly dividend by 4.9%, to $1.71 from $1.63. The new payout, equal to $6.84 a year, represents an ...

Analyst David Windley from Jefferies maintained a Buy rating on Elevance Health (ELV – Research Report) and increased the price target to ...

In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

Reviewed by Caitlin Clarke Fact checked by Vikki Velasquez The Dow Jones Industrial Average, also known as the Dow or DJIA, ...

Investing.com -- Elevance Health Inc. reported fourth quarter earnings that missed analyst expectations, but the health insurer's shares rose following the release. The company posted adjusted ...

Shares of Elevance Health jumped early Thursday in response to better-than-expected fourth- quarter results, and a generally optimistic outlook for the coming year. A week after UnitedHealth Group ...

The latest trading week ended on a very sour note, given that the average stock in the broad-based Russell 3000 index declined 1.2% on Friday, even as the Dow Jones Industrial Average managed to ...